Answers are grounded in this paper and cite their sources.
Molecular design of boron subphthalocyanine complexes achieves 98% efficiency in CO2 reduction, suggesting potential advancements in electroreduction technology.
This study presents molecular boron subphthalocyanine complexes precursors ((Cl-B-SubPc) 1 and (Cl-B-SubPc-OC12H23) 2), designed for efficient CO2 reduction. The resulting heterogeneous catalysts exhibit remarkable overall efficiencies of 98%, integrated into...
No takes yet. Share an insight, caveat, or question.
Yari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: